About: Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 04 May 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) artículu científicu espublizáu en mayu de 2020 (ast) наукова стаття, опублікована 4 травня 2020 (uk) scientific article published on 04 May 2020 (en)
publication date	wds:Q94521029-B161C2C6-8890-4937-90DF-D583A2AE5140
publication date	2020-05-04 00:00:00Z (xsd:dateTime)
cites work	wds:Q94521029-08509C7E-746A-4536-BE54-8254F13F0432 wds:Q94521029-0A49FCFF-6603-486F-ABFB-5A62677AED81 wds:Q94521029-1400A2A2-B7F9-4BE7-BE22-80EE9CFDA615 wds:Q94521029-149AD4F5-2F6D-4E50-A408-7C0A5840BA50 wds:Q94521029-171440D8-6BCA-4C4E-9A7F-B2980936BBE6 wds:Q94521029-234D453C-DFB3-4BA4-B6B9-6408A794B9C4 wds:Q94521029-293C0557-8D48-4318-B926-1583179EFA32 wds:Q94521029-2A6C0E15-6C8F-41E0-96C2-5133E71A2782 wds:Q94521029-3A0D9E91-699F-47F7-8212-2CEBE42C6D50 wds:Q94521029-47A46182-BF7B-44E0-9018-AF810BE75964 wds:Q94521029-4AA9A676-D75A-4934-BAE0-2E3B2BF472A2 wds:Q94521029-51BAF18A-9235-425D-A10F-65A03E137DFC wds:Q94521029-573EB466-2C50-47F4-92E8-F16F7F819B37 wds:Q94521029-587F662C-0287-4B1D-9E2A-9E6E92B28D12 wds:Q94521029-77DA1E05-359A-4B33-B176-52C43430C4AE wds:Q94521029-7DAE661D-78C0-4CC4-820B-C9B8F6E532E2 wds:Q94521029-80D0CADA-AACA-4037-9355-E933B824413A wds:Q94521029-8CB3D929-DFFD-46CC-B5CB-95A2F65882FD wds:Q94521029-93E52063-30F7-47FE-8FED-84CD5C8AB41B wds:Q94521029-96543F36-6E5A-4B25-B60B-B7869B67FA50 wds:Q94521029-971C549D-42E6-4BB2-B4FC-3CA90E19F62D wds:Q94521029-A606C380-8F6C-4F04-A78B-23A86C8202F6 wds:Q94521029-A81D6037-5DF1-4B12-B3B3-4F625A27D583 wds:Q94521029-AFB146FA-4B4F-4D1B-ACF6-B553630F398B wds:Q94521029-D5698191-4428-4C1C-96CB-7C5AAE49DDE2 wds:Q94521029-DBDD7A82-83C1-4D86-B8F3-CF004741AC01 wds:Q94521029-ED1DE5BB-D6C8-40A8-8FB4-E39F3C416A2D wds:Q94521029-F70FFB35-3536-4E8E-A1F1-BD2675F102FF
cites work	Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Prognosis in therapy-related acute myeloid leukemia and impact of karyotype The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies Genetics of therapy-related myelodysplasia and acute myeloid leukemia Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome Acute myeloid leukaemia Myeloid neoplasms after breast cancer: "therapy-related" not an independent poor prognostic factor Therapy of secondary leukemia Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials Reasons for treating secondary AML as de novo AML
author name string	wds:Q94521029-209D3E4D-FC6E-4002-87CE-C676E0F32DF5 wds:Q94521029-2429BBC2-3E22-4EAF-9E96-99AEE81C1DF1 wds:Q94521029-257C3815-E1A2-4EA0-946A-FA0026576693 wds:Q94521029-2CB83856-EE8E-4DF2-8DDF-4E4F2816BD39 wds:Q94521029-331E990D-E0C5-49A4-BB93-86F8D846F0BC wds:Q94521029-3CC9D475-9687-4FE6-942C-738433E7C7F6 wds:Q94521029-7F284A9E-0340-4CBD-A5B9-333600F810C4 wds:Q94521029-8A13433C-B07D-47B9-930A-5101DE31BE90 wds:Q94521029-A93B098C-BF0B-41A2-ADDE-B197BADAA69D wds:Q94521029-B548CC61-EC9F-4BAA-B398-8E8CB2938CF4 wds:Q94521029-C3761ED7-BABB-4AAA-AF8A-B2D0DA5185F3 wds:Q94521029-C5A1E5EF-6053-47E5-8DF2-682C0FD7D5F4
author name string	Musa Yilmaz Farhad Ravandi Hagop Kantarjian Sherry Pierce Jorge E Cortes Gautam Borthakur Tapan M Kadia Naval Daver Maro Ohanian Nicholas J Short Marina Y Konopleva Guillaume Richard-Carpentier
rdfs:label	Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype (en) Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype (nl)
skos:prefLabel	Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype (en) Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype (nl)
name	Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype (en) Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype (nl)
author	wds:Q94521029-33D41F13-21E7-4EE1-9699-CB0C08470534 wds:Q94521029-380EAAB5-3A38-4BF3-8E44-B90209B9825C wds:Q94521029-554968E8-DFCA-4B76-BA74-EEB759825B48 wds:Q94521029-8BC680F5-8777-47BD-A067-9CDD5C34A3A3 wds:Q94521029-A9DC0DB2-44E2-4C26-95B6-3AD6701F7E47
author	Guillermo Garcia-Manero

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software